drugset / Trial / NCT01184144

Endometriosis: Immunomodulation

NCT01184144

Phase 2/3 Withdrawn University of Wisconsin, Madison
RandomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this study is to compare the effect of pioglitazone versus no drug on soluble profinflammatory markers in peritoneal fluid of women with endometriosis.

Timeline

Start
2010-08
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule 30 mg Oral

Indications